Clinical Intelligence for the Entire Cancer Journey

Technology built to support cancer detection, diagnosis, and treatment optimization—driven by proven AI and global-scale clinical insights.

Setting the Standard for AI in Cancer Care

Clinical intelligence built for scale, synergy, and impact

Lunit’s clinical intelligence platform spans AI-powered cancer diagnostics, detection, treatment planning, and biomarker/CDx development—bringing together a range of solutions designed to work seamlessly across the care continuum.

More than standalone tools, these clinically validated systems serve as engines of insight—powered by diverse, large-scale data and built for interoperability and synergy.

Together, they form the foundation for a future-ready, multimodal approach to innovation in cancer care at scale.

What Makes Lunit’s Technology Different

Built on world-class data

Built on world-class data

We train our AI solutions on millions of expertly annotated images—including CXR, MMG, DBT, H&E, and IHC—sourced through global clinical partnerships. This high-quality, diverse dataset drives more reliable, generalizable performance across cancer applications.

Proven in real-world practice

Proven in real-world practice

With FDA-cleared and CE-marked (under MDR) products used at 10,000+ sites in 65+ countries, our AI cancer solutions are clinically validated and globally trusted.

A future-ready foundation model strategy

A future-ready foundation model strategy

We’re optimizing adaptable AI to meet the needs of modern cancer care, improving performance through continuous R&D and strategic acquisitions. As a long-term innovation partner, we’re advancing toward a scalable future built on next-generation foundation models.

Powered by multimodal data integration

Powered by multimodal data integration

Our multimodal AI leverages diverse data types across domains—imaging, clinical, tissue, and molecular—to power more accurate detection, personalized risk stratification, advanced spatial analysis, and innovative biomarker development.

Trusted by
Clinical and Industry Leaders

Lunit INSIGHT MMG (2D)

“As the first breast radiologist to use AI in daily practice in the Kingdom, I truly believe in its power to enhance accuracy and efficiency. Lunit has proven to be a reliable partner, seamlessly integrating into our workflow and elevating the quality of breast imaging care we provide.”

Dr. Fatina M. Al Tahan
Dr. Fatina M. Al Tahan
Senior Consultant at Dr. Sulaiman Al Habib Medical Group,
Kingdom of Saudi Arabia
Lunit INSIGHT CXR

“Our hospital is overflowing with patients while the number of radiologists remains low. Lunit INSIGHT CXR is providing great help, especially for patient triage and monitoring.”

Dr. Fabrício Próspero Machado
Dr. Fabrício Próspero Machado
Radiologist at Prevent Senior Hospital, Brazil
Advance Your Cancer Care Strategy with AI

Advance Your Cancer Care Strategy with AI

Connect with us to see how AI for radiology and oncology can elevate your detection, diagnostics, treatment planning, and biomarker development with real-world-proven tools.

Frequently Asked Questions

What makes Lunit’s AI technology different from other medical AI companies?

Most medical AI tools solve a single problem in a single clinical setting. Lunit builds an integrated suite of solutions that span the cancer care continuum–from screening and diagnosis to treatment guidance. Each solution is designed to work in synergy, forming a connected platform that supports better clinical decision-making.